Re:Experimental Drug Likely Saved Ebola Patients
by rayiner on Tuesday August 05, 2014 @11:46AM
(#8137523)
There was a quote in an article yesterday, where a doctor at Emory basically said: our treatment strategy with Ebola is just to keep the patient alive long enough for the body's immune system to fight the disease. People don't die of the bleeding per se, but the fluid loss and organs going into shock: http://www.latimes.com/science/sciencenow/la-sci-sn-ebola-vi.... A doctor in that article estimates that the mortality rate with proper medical care is more like 45-55%.
So the proper base rate to consider for an experimental treatment with respect to U.S. persons is not the 90% mortality rate in Africa, but the ~50% mortality rate that might be expected of someone in a hospital here in the U.S.
While trying to find a description of this, it looks like FiveThirtyEight put something together on the exact topic: http://fivethirtyeight.com/datalab/we-still-dont-know-how-de...
As for using experimental drugs, there are certainly times when the probability of death may seem dramatically increased for one patient relative to the overall survival numbers. "Certainty" for a population is one thing, "certainty" for some patients can be more (but not entirely) clear.